Key Therap patent expiration

1. Zontivity patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7235567 KEY THERAP Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
Jun, 2021

(3 years ago)

US7713999 KEY THERAP Thrombin receptor antagonists
May, 2024

(a month ago)

US7304078 KEY THERAP Thrombin receptor antagonists
Dec, 2027

(3 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) May 08, 2019

Drugs and Companies using VORAPAXAR SULFATE ingredient

NCE-1 date: 08 May, 2018

Market Authorisation Date: 08 May, 2014

Treatment: Reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (mi) or with peripheral arterial disease (pad); Reduction of thrombotic cardiovascular events

Dosage: TABLET

More Information on Dosage

ZONTIVITY family patents

Family Patents